SEC Form 4 · accession 0001179110-18-011368
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryant David Lim
Officer — SVP and General Counsel
Period of report
Sep 10, 2018
Accepted (ET)
Sep 13, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.29 | Sep 10, 2018 | A | 130,000 | A | — | Sep 10, 2028 | Common Stock | 130,000 | 130,000 | D |
Explanation of responses
- F1The option was granted under the Company's 2013 Stock Incentive Plan. The option vests and becomes exercisable over a four-year period commencing on September 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on September 10, 2019 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.